Extrapontine myelinolysis in a patient with systemic lupus erythematosus: A case report

Journal of the Formosan Medical Association

Volumn 101, Issue 7, 2002, Pages 505-508

  Tsai, Ming Han ^a   Lu, Chin Song ^a   Chen, Chi Jen ^a   Tsai, Wen Pin ^a   Liou, Lieh Bang ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Extrapontine myelinolysis; Hyponatremia; Systemic lupus erythematosus

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTINUCLEAR ANTIBODY; ASPARTATE AMINOTRANSFERASE; CARDIOLIPIN ANTIBODY; CEFTIZOXIME; CREATININE; DNA ANTIBODY; HEMOGLOBIN; HYDROCORTISONE; HYDROXYCHLOROQUINE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LEVODOPA; METOCLOPRAMIDE; POTASSIUM CHLORIDE; POTASSIUM ION; PREDNISOLONE; RIBONUCLEOPROTEIN ANTIBODY; SERUM ALBUMIN; SERUM GLOBULIN; SODIUM CHLORIDE; SODIUM ION; TRIHEXYPHENIDYL; VASOPRESSIN;

ADULT; ARTICLE; BRADYKINESIA; BRAIN EDEMA; BRAIN HYPOXIA; BRAIN INJURY; CASE REPORT; CENTRAL PONTINE MYELINOLYSIS; CONSCIOUSNESS; DISEASE COURSE; FEMALE; GLOBUS PALLIDUS; HUMAN; HYPONATREMIA; INAPPROPRIATE VASOPRESSIN SECRETION; METABOLIC ENCEPHALOPATHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSONISM; PUTAMEN; RIGIDITY; SEPSIS; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC VASCULITIS; THALAMUS; TREMOR; VOMITING;

FEMALE; HUMANS; HYPONATREMIA; INAPPROPRIATE ADH SYNDROME; LUPUS ERYTHEMATOSUS, SYSTEMIC; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; MYELINOLYSIS, CENTRAL PONTINE;

EID: 0036657098     PISSN: 09296646     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Hochberg MC: Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997;40: 1725.
2. Miller M: Syndromes of excess antidiuretic hormone release. Critical Care Clinics 2001;17:11-23.
3. Singer GG, Brenner BM: Fluid and electrolyte disturbances. In: Harrison TW, Braunwald E, eds. Harrison's Principles of Internal Medicine. 15th ed. New York: Mc-Graw-Hill, 2001;271-83.
4. Elisaf MS, Milionis HJ, Drosos AA: Hyponatremia due to inappropriate secretion of antidiuretic hormone in a patient with systemic lupus erythematosus. Clin Exp Rheumatol 1999;17:223-6.
5. Norenberg MD: A hypothesis of osmotic endothelial injury. A pathogenetic mechanism in central pontine myelinolysis. Arch Neurol 1983;40:66-9.
6. Chen CJ, Huang CC, Ro LS: Evolution of pontine and extrapontine myelinolysis. Clinical correlation with serial CT and MRI studies. Eur Neurol 1996;36:179-80.
7. Brown WD: Osmotic demyelinolysis disorders: central pontine and extrapontine myelinolysis. Curr Opin Neurol 2000;13:691-7.
8. Shields DC, Banik NL: Pathophysiological role of calpain in experimental demyelination. J Neurosci Res 1999; 55:533-41.
9. Nagamitsu S, Matsuishi T, Yamashita Y, et al: Extrapontine myelinolysis with parkinsonism after rapid correction of hyponatremia: high cerebrospinal fluid level of homovanillic acid and successful dopaminergic treatment. J Neural Transm 1999;106:949-53.
10. Sadeh M, Goldhammer Y: Extrapyramidal syndrome responsive to dopaminergic treatment following recovery from central pontine myelinolysis. Eur Neurol 1993; 33:48-50.
11. Drenkard C, Villa AR, Reyes E, et al: Vasculitis in systemic lupus erythematosus. Lupus 1997;6:235-42.
12. Shahar E, Goshen E, Tauber Z, et al: Parkinsonian syndrome complicating systemic lupus erythematosus. Pediatr Neurol 1998;18:456-8.